What does STERIGENICS BELGIUM (FLEURUS) do?

STERIGENICS BELGIUM (FLEURUS) is a cleaning company in Fleurus. Private Limited, started on 26 November 1990, 1 establishment.

What is the address of STERIGENICS BELGIUM (FLEURUS)?

The registered office of STERIGENICS BELGIUM (FLEURUS) is located at Avenue de l'Espérance(F) 17, 6220 Fleurus.

Is STERIGENICS BELGIUM (FLEURUS) still active?

Yes. According to the CBE (29 October 2026) STERIGENICS BELGIUM (FLEURUS) is active, legal situation “Normale toestand”, started on 26 November 1990.

Is STERIGENICS BELGIUM (FLEURUS) registered on Peppol?

Yes, STERIGENICS BELGIUM (FLEURUS) is registered on the Peppol network with ID 0208:0442042064.

What is the enterprise number of STERIGENICS BELGIUM (FLEURUS)?

The enterprise number of STERIGENICS BELGIUM (FLEURUS) is BE0442042064.

When was STERIGENICS BELGIUM (FLEURUS) founded?

STERIGENICS BELGIUM (FLEURUS) was founded on 26 November 1990.

Who are the directors of STERIGENICS BELGIUM (FLEURUS)?

According to the 2025 annual accounts, the directors of STERIGENICS BELGIUM (FLEURUS) are: Robin Van Den Bergh, Lars Pontus Rundstrom, Giuseppe Ritaccio.

Is STERIGENICS BELGIUM (FLEURUS) a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 November 1990; 4 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did STERIGENICS BELGIUM (FLEURUS) make in 2025?

STERIGENICS BELGIUM (FLEURUS) posted a profit after taxes of € 6,058,512 in financial year 2025.

What is the revenue of STERIGENICS BELGIUM (FLEURUS)?

In its most recent annual accounts (2025), STERIGENICS BELGIUM (FLEURUS) reported revenue of € 18,427,131.

How much does an employee at STERIGENICS BELGIUM (FLEURUS) earn?

The average wage cost per full-time employee at STERIGENICS BELGIUM (FLEURUS) was € 84,200 in 2025: staff costs of € 3.8 million for 45.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does STERIGENICS BELGIUM (FLEURUS) have?

According to the 2025 annual accounts, STERIGENICS BELGIUM (FLEURUS) has 45.7 full-time equivalents (FTE).

STERIGENICS BELGIUM (FLEURUS) (Private Limited) - Fleurus

Dossier STERIGENICS BELGIUM (FLEURUS), printed on 29 October 2026 from databakkes.be/en/0442042064/sterigenics-belgium-fleurus. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

STERIGENICS BELGIUM (FLEURUS) from Fleurus, company number BE0442042064, closed financial year 2025 with a result of € 6.1 million after tax. For that financial year STERIGENICS BELGIUM (FLEURUS) recorded revenue of € 18.4 million and equity of € 14.7 million. Compared with financial year 2024, the result moved from € 6.3 million to € 6.1 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Growing

€ 14.7 million

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 6.1 million

▼ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 465

▼ 56% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 4.1 million paid out

68 % of the profit went to the shareholders, mostly to Nelson Labs NV (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

45.7

▼ 1.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 4.5 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 3.8 million

▲ 3% vs 2024

€ 84,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 78,517

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 434,381

▲ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 32 days on average.

Wages and social charges

€ 446,322

▼ 23% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 14,279,734 Revenue 2022: € 14,279,734 First fiscal year in the series	€ 17,468,815 Revenue 2023: € 17,468,815 ▲ 22% vs 2022 (€ 14,279,734) Favourable step	€ 18,118,683 Revenue 2024: € 18,118,683 ▲ 4% vs 2023 (€ 17,468,815) Favourable step	€ 18,427,131 Revenue 2025: € 18,427,131 ▲ 2% vs 2024 (€ 18,118,683) Favourable step	▲ 2%
Profit after taxes	€ 4,253,726 Profit after taxes 2022: € 4,253,726 First fiscal year in the series	€ 6,544,306 Profit after taxes 2023: € 6,544,306 ▲ 54% vs 2022 (€ 4,253,726) Favourable step	€ 6,306,478 Profit after taxes 2024: € 6,306,478 ▼ 4% vs 2023 (€ 6,544,306) Unfavourable step	€ 6,058,512 Profit after taxes 2025: € 6,058,512 ▼ 4% vs 2024 (€ 6,306,478) Unfavourable step	▼ 4%
Equity	€ 14,525,497 Equity 2022: € 14,525,497 First fiscal year in the series	€ 21,069,803 Equity 2023: € 21,069,803 ▲ 45% vs 2022 (€ 14,525,497) Favourable step	€ 12,723,878 Equity 2024: € 12,723,878 ▼ 40% vs 2023 (€ 21,069,803) Unfavourable step	€ 14,680,667 Equity 2025: € 14,680,667 ▲ 15% vs 2024 (€ 12,723,878) Favourable step	▲ 15%
Total debts	€ 1,312,463 Total debts 2022: € 1,312,463 First fiscal year in the series	€ 1,613,006 Total debts 2023: € 1,613,006 ▲ 23% vs 2022 (€ 1,312,463) Unfavourable step	€ 1,066,499 Total debts 2024: € 1,066,499 ▼ 34% vs 2023 (€ 1,613,006) Favourable step	€ 1,006,638 Total debts 2025: € 1,006,638 ▼ 6% vs 2024 (€ 1,066,499) Favourable step	▼ 6%
Cash	€ 302 Cash 2022: € 302 First fiscal year in the series	€ 1,106 Cash 2023: € 1,106 ▲ 266% vs 2022 (€ 302) Favourable step	€ 1,051 Cash 2024: € 1,051 ▼ 5% vs 2023 (€ 1,106) Unfavourable step	€ 465 Cash 2025: € 465 ▼ 56% vs 2024 (€ 1,051) Unfavourable step	▼ 56%
Land & buildings	€ 1,961,068 Land & buildings 2022: € 1,961,068 First fiscal year in the series	€ 2,030,606 Land & buildings 2023: € 2,030,606 ▲ 4% vs 2022 (€ 1,961,068) Unchanged	€ 1,964,768 Land & buildings 2024: € 1,964,768 ▼ 3% vs 2023 (€ 2,030,606) Unchanged	€ 1,950,859 Land & buildings 2025: € 1,950,859 ▼ 1% vs 2024 (€ 1,964,768) Unchanged	▼ 1%
Retained profit	€ 8,691,497 Retained profit 2022: € 8,691,497 First fiscal year in the series	€ 15,235,803 Retained profit 2023: € 15,235,803 ▲ 75% vs 2022 (€ 8,691,497) Favourable step	€ 6,889,878 Retained profit 2024: € 6,889,878 ▼ 55% vs 2023 (€ 15,235,803) Unfavourable step	€ 8,846,667 Retained profit 2025: € 8,846,667 ▲ 28% vs 2024 (€ 6,889,878) Favourable step	▲ 28%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 14,652,403 Dividend 2024: € 14,652,403 Unchanged (€ 0) Unchanged	€ 4,101,723 Dividend 2025: € 4,101,723 ▼ 72% vs 2024 (€ 14,652,403) Unchanged	▼ 72%
Balance sheet total	€ 16,547,960 Balance sheet total 2022: € 16,547,960 First fiscal year in the series	€ 23,392,809 Balance sheet total 2023: € 23,392,809 ▲ 41% vs 2022 (€ 16,547,960) Unchanged	€ 14,500,377 Balance sheet total 2024: € 14,500,377 ▼ 38% vs 2023 (€ 23,392,809) Unchanged	€ 16,397,305 Balance sheet total 2025: € 16,397,305 ▲ 13% vs 2024 (€ 14,500,377) Unchanged	▲ 13%
Employees (FTE)	42.1 Employees (FTE) 2022: 42.1 First fiscal year in the series	45.1 Employees (FTE) 2023: 45.1 ▲ 3 vs 2022 (42.1) Unchanged	47.5 Employees (FTE) 2024: 47.5 ▲ 2.4 vs 2023 (45.1) Unchanged	45.7 Employees (FTE) 2025: 45.7 ▼ 1.8 vs 2024 (47.5) Unchanged	▼ 1.8

Key figures of STERIGENICS BELGIUM (FLEURUS), fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to STERIGENICS BELGIUM (FLEURUS)?

What happened at STERIGENICS BELGIUM (FLEURUS) in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Robin Van Den Bergh stepped down as director. NBB
Jul 23, 2026 New annual accounts for financial year 2025: profit of € 6.1 million (▼ 4% vs 2024). Source: NBB ↗
2026 Giuseppe Ritaccio stepped down as director. NBB
2025 Robin Van Den Bergh became a director. NBB
2025 Lars Pontus Rundstrom stepped down as director. NBB
2020 Lars Pontus Rundstrom became a director. NBB
2020 Giuseppe Ritaccio became a director. NBB
Dec 12, 1990 New establishment in Fleurus. KBO

In short

From € 4.3 million profit in 2022 to € 6.1 million profit in 2025.

Paid € 8.2 million in corporate taxes since 2022.

Best year ever: 2023, with € 6.5 million profit.

Paid out € 18.8 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Nelson Labs NV 100%

STERIGENICS 100%

The stake of STERIGENICS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

STERIGENICS BELGIUM (FLEURUS)

The shares are held by Nelson Labs NV (100%) and STERIGENICS (100%).

Directors

According to the 2025 annual accounts

Robin Van Den Bergh

Director

since 2025 · until 2031

Lars Pontus Rundstrom

Director

since 2020 · until 2025

Giuseppe Ritaccio

Director

since 2020 · until 2026

Shareholders

Nelson Labs NV

100%

STERIGENICS

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue de l'Espérance(F) 17

6220 Fleurus

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0442.042.064

VAT number

BE 0442.042.064

Registered office

Avenue de l'Espérance(F) 17, 6220 Fleurus

Names & denominations

STERIGENICS BELGIUM (FLEURUS)

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 November 1990

Peppol

Active · Active since 2 Jan 2026

Activities · NACE

Overige reiniging van gebouwen; industriële reiniging

Industriële reiniging

Activiteiten van verpakkingsbedrijven

View on CBE Public ↗ Annual accounts (NBB) ↗

STERIGENICS BELGIUM (FLEURUS)

Financials

What happened to STERIGENICS BELGIUM (FLEURUS)?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions